GleamWall
中文EN

BEAM Beam Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1745999 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY163.3%
TTM net income YoY74.1%
TTM EPS YoY80.0%
Revenue 3-yr CAGR21.6%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-267.7%
Net margin-73.0%
FCF margin-271.6%
EBITDA margin-252.6%

Returns

ROE-11.1%
ROA-8.3%
ROIC (approx.)-40.2%
Asset turnover0.11x

Leverage & solvency

Liabilities / assets24.9%
Debt / equity0.11x
Current ratio13.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.63x
Accruals ratio21.8%
Payout ratio—
Capex / revenue6.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$139.74M$63.52M
R&D expense$409.62M$367.56M
SG&A expense$113.82M$111.53M
Operating income-$383.69M-$415.57M
Pretax income-$79.99M-$376.70M
Income tax$0$39,000
Net income-$79.99M-$376.74M
EBITDA-$361.40M-$393.64M
EPS (basic)-0.81-4.58
EPS (diluted)-0.81-4.58
Weighted avg. shares (diluted)98.91M82.31M
Balance sheet
Cash & equivalents$294.94M$290.11M
Short-term investments$950.27M$568.77M
Current assets$1.27B$878.15M
PP&E, net$104.50M$111.41M
Total assets$1.48B$1.10B
Current liabilities$96.94M$182.07M
Total liabilities$242.82M$370.28M
Shareholders' equity$1.24B$733.54M
Shares outstanding101.75M83.63M
Cash flow statement
Operating cash flow-$345.10M-$347.25M
Capital expenditure$14.95M$8.95M
Free cash flow-$360.05M-$356.19M
Investing cash flow-$121.44M$185.01M
Financing cash flow$478.05M$7.74M
Depreciation & amortization$22.29M$21.93M
Stock-based compensation$94.24M$120.66M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.